Kayse J Aho, CCC, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 705 Pleasant Ave S, Park Rapids, MN 56470 Phone: 218-847-5611 |
Rita Kleven Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 200 Main Ave S, Park Rapids, MN 56470 Phone: 218-732-0868 Fax: 218-732-8502 |
Kia Danielle Alton, SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 705 Pleasant Ave S, Park Rapids, MN 56470 Phone: 218-732-2800 |
Mrs. Heather Jan Schultz, M.A., CCC-SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: Telemedicine Services, 501 Eastern Ave S, Park Rapids, MN 56470 Phone: 319-471-8328 |
Jessie Ramona Clark, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 600 Pleasant Ave S, Park Rapids, MN 56470 Phone: 218-616-3014 |
News Archive
Antibiotic resistance is a big threat to global health, and a growing number of infections are now becoming harder to treat. The usual treatments, like antibiotics used to treat them, becomes less effective. Now, a team of researchers may have found a potent weapon against antibiotic-resistant bacteria, which can help treat persistent infections.
But the department is expected to continue investigating the use of "most-favored-nation" pricing contracts in other states.
A new study shows that abstinence from alcohol is linked to dementia. The study titled, "Alcohol consumption and risk of dementia: 23 year follow-up of Whitehall II cohort study," results appear in the latest issue of the British Medical Journal.
The number of U.S. residents who receive cash payments from welfare has decreased since the enactment of a reform law in 1996, but enrollment in other public programs for low-income residents, such as Medicaid, has increased over the same period, according to a recent analysis by the Associated Press, the AP/Contra Costa Times reports.
AstraZeneca and MAP Pharmaceuticals, Inc. have announced an exclusive worldwide agreement to develop and commercialize Unit Dose Budesonide (UDB), MAP Pharmaceuticals' proprietary nebulized formulation of budesonide.
› Verified 4 days ago